These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation. Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893 [TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus after heart transplantation: definitions for the guidance of antiviral therapy. Iberer F; Tscheliessnigg K; Halwachs G; Auer T; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayer T; Prenner G Scand J Infect Dis Suppl; 1995; 99():100-3. PubMed ID: 8668929 [TBL] [Abstract][Full Text] [Related]
4. A prospective study of the usefulness of rapid diagnostic tests in monitoring cytomegalovirus infection in renal transplants. Gómez E; Aguado S; Melón S; Martínez A; de Oña M; Cimadevilla R; Gorostidi M; González E; Alvarez Grande J Transplant Proc; 1992 Dec; 24(6):2631-3. PubMed ID: 1334588 [No Abstract] [Full Text] [Related]
5. Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood. Baldanti F; Simoncini L; Sarasini A; Zavattoni M; Grossi P; Revello MG; Gerna G Transplantation; 1998 Aug; 66(3):324-9. PubMed ID: 9721800 [TBL] [Abstract][Full Text] [Related]
7. Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. Gerna G; Lilleri D; Zecca M; Alessandrino EP; Baldanti F; Revello MG; Locatelli F Haematologica; 2005 Apr; 90(4):526-33. PubMed ID: 15820949 [TBL] [Abstract][Full Text] [Related]
8. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction. Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310 [TBL] [Abstract][Full Text] [Related]
9. [Incidence, prevention and therapy of cytomegalovirus and pneumocystis carinii pneumonia after liver transplantation]. Lauchart W Med Klin (Munich); 1992 Oct; 87 Suppl 1():60-4. PubMed ID: 1334223 [No Abstract] [Full Text] [Related]
10. Rising CMV PP65 antigenemia and DNA levels during preemptive antiviral therapy. Boeckh M Haematologica; 2005 Apr; 90(4):439. PubMed ID: 15820936 [No Abstract] [Full Text] [Related]
11. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease]. Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888 [TBL] [Abstract][Full Text] [Related]
12. [Incidence, therapy and prevention of cytomegalovirus disease after bone marrow transplantation]. Schuler U; Ehninger G Med Klin (Munich); 1992 Oct; 87 Suppl 1():30-8. PubMed ID: 1334220 [No Abstract] [Full Text] [Related]
13. Cytomegalovirus disease after liver transplantation: diagnostics and therapy. Wiens M; Schmidt CA; Lohmann R; Oettle H; Blumhardt G; Neuhaus P Transplant Proc; 1993 Aug; 25(4):2673-4. PubMed ID: 8395108 [No Abstract] [Full Text] [Related]
14. [Clinical aspects and therapy of infection with cytomegalovirus]. Reusser P Internist (Berl); 1992 Sep; 33(9):593-6. PubMed ID: 1328108 [No Abstract] [Full Text] [Related]
15. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay. Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717 [TBL] [Abstract][Full Text] [Related]
16. Is determination of PP 65 useful for early diagnosis of cytomegalovirus infection in renal transplantation? Klauser R; Kotzmann H; Wamser P; Braza P; Popov-Kraupp T; Franz M; Traindl O; Watschinger B; Pohanka E; Mühlbacher F Transplant Proc; 1992 Dec; 24(6):2628-30. PubMed ID: 1334587 [No Abstract] [Full Text] [Related]
17. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients. Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637 [TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience. Manteiga R; Martino R; Sureda A; Labeaga R; Brunet S; Sierra J; Rabella N Bone Marrow Transplant; 1998 Nov; 22(9):899-904. PubMed ID: 9827819 [TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus surveillance following liver transplantation: does it allow presymptomatic diagnosis of cytomegalovirus disease? Umana JP; Mutimer DJ; Shaw JC; McLeish PJ; Buchan A; Martin B; Neuberger JM; Elias E; McMaster P Transplant Proc; 1992 Dec; 24(6):2643-5. PubMed ID: 1334593 [No Abstract] [Full Text] [Related]
20. Serial interleukin-6 blood levels early after cardiac transplantation. Weyand M; Krehmeier M; Fahrenkamp A; Middendorf C; Redmann M; Schwartz C; Konertz W; Scheld HH Transplant Proc; 1992 Dec; 24(6):2546. PubMed ID: 1334584 [No Abstract] [Full Text] [Related] [Next] [New Search]